Periodic Reporting for period 1 - DDBSD (Diagnostic Test For The Differential Diagnosis of Bipolar Disorder and Major Depressive Disorder)

Neuropsychiatric disorders contribute 13% to the global burden of disease and cost the European economy an estimated 789bn EUR a year. Psyomics is a Cambridge-based biotechnology start-up focussed on reducing this burden by providing scientifically-validated solutions that...